Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Oncol., 24 July 2025

Sec. Gynecological Oncology

Volume 15 - 2025 | https://doi.org/10.3389/fonc.2025.1661708

Correction: Severe thrombocytopenia induced by niraparib in ovarian cancer patients: a case report and literature review

This article is a correction to:

  1. Severe Thrombocytopenia Induced by Niraparib in Ovarian Cancer Patients: A Case Report and Literature Review

    1. Read original article
Jiajun Li&#x;Jiajun Li1†Jiaxi Yang&#x;Jiaxi Yang2†Ying Wang*Ying Wang2*
  • 1Department of Pharmacology, Hebei Medical University, Shijiazhuang, China
  • 2Department of Gynecology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China

A Correction on
Severe thrombocytopenia induced by niraparib in ovarian cancer patients: a case report and literature review

By Li J, Yang J and Wang Y (2025). Front. Oncol. 15:1542646. doi: 10.3389/fonc.2025.1542646

Author “Jiaxi Yang” was erroneously spelled as “Jiaqian Yang”.

In the published article, there was a mistake in the Author name. The Author name for the co-first author was misspelled as “Jiaqian Yang”. The correct spelling is “Jiaxi Yang’’

A correction has been made to the Keywords. The numbers after each keyword were removed as they did not carry significance.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: poly (ADP-ribose) polymerase inhibitor, niraparib, ovarian cancer, thrombocytopenia, case report

Citation: Li J, Yang J and Wang Y (2025) Correction: Severe thrombocytopenia induced by niraparib in ovarian cancer patients: a case report and literature review. Front. Oncol. 15:1661708. doi: 10.3389/fonc.2025.1661708

Received: 08 July 2025; Accepted: 09 July 2025;
Published: 24 July 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Li, Yang and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ying Wang, MTU4MzM5MjUxNDFAMTM5LmNvbQ==

†These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.